Lucas L. Van Den Hoogen

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Implications of 2023 ACR/EULAR classification criteria for antiphospholipid syndrome and current diagnostic and therapeutic insights: A Delphi consensus.

Implications of 2023 ACR/EULAR classification criteria for antiphospholipid syndrome and current diagnostic and therapeutic insights: A Delphi consensus.

Journal: The American journal of medicine

Published: December 01, 2025

Development and validation of a EULAR disease activity score in antiphospholipid syndrome.

Development and validation of a EULAR disease activity score in antiphospholipid syndrome.

Journal: Annals of the rheumatic diseases

Published: April 23, 2025

Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus.

Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus.

Journal: Journal of translational autoimmunity

Published: May 20, 2024

A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome.

A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome.

Journal: medRxiv : the preprint server for health sciences

Published: February 26, 2024

A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome.

A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 13, 2024

B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?

B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?

Journal: Journal of clinical medicine

Published: November 17, 2022

Targeting thromboinflammation in antiphospholipid syndrome.

Targeting thromboinflammation in antiphospholipid syndrome.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 07, 2022

Signaling by the inhibitory receptor CD200R is rewired by type I interferon.

Signaling by the inhibitory receptor CD200R is rewired by type I interferon.

Journal: Science signaling

Published: October 12, 2021

Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren's syndrome.

Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren's syndrome.

Journal: Best practice & research. Clinical rheumatology

Published: February 19, 2020

Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.

Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.

Journal: Rheumatology (Oxford, England)

Published: October 31, 2019

Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome.

Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome.

Journal: Annals of the rheumatic diseases

Published: May 26, 2019

Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.

Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.

Journal: Immunity

Published: March 03, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026